Moneycontrol PRO
HomeNewsBusinessStocksNifty top losers: Larsen & Toubro, Sun Pharma, HCL Tech stocks drag on Nifty 50 index today

Nifty top losers: Larsen & Toubro, Sun Pharma, HCL Tech stocks drag on Nifty 50 index today

Moneycontrol analysis indicates a very bullish sentiment for the stock as of August 18, 2025.

August 18, 2025 / 10:41 IST
Disclaimer This is an AI-assisted live blog with updates from multiple sources Disclaimer

Several stocks experienced declines in Monday's trading session, with Larsen & Toubro, Sun Pharma, HCL Tech, Infosys and ITC among the top losers on the Nifty 50. At 10:30 am, Larsen & Toubro was trading at Rs 3,641.10, a 0.98% fall from the previous close. Sun Pharma was trading at Rs 1,634.50, down by 0.42%, HCL Tech at Rs 1,483.60, also down by 0.42%, Infosys at Rs 1,442.50, a 0.36% decrease and ITC at Rs 410.25, declining by 0.29%.

Larsen & Toubro Financial Overview:

Larsen & Toubro's consolidated revenue for the quarter-ending June 2025 stood at Rs 63,678.92 Crore, compared to Rs 55,119.82 Crore in June 2024. The net profit for the same quarter was Rs 4,325.57 Crore, up from Rs 3,440.11 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 26.30, compared to Rs 20.26 in June 2024.

The company's annual consolidated revenue for the year 2025 reached Rs 255,734.45 Crore, a notable increase from Rs 221,112.91 Crore in 2024. The net profit for the year was Rs 17,687.39 Crore, compared to Rs 15,569.72 Crore in the previous year. The EPS for 2025 was Rs 109.36, up from Rs 93.96 in 2024. The Book Value Per Share (BVPS) decreased to Rs 710.12 in 2025 from Rs 746.01 in 2024. The Return on Equity (ROE) slightly increased to 15.39% in 2025 from 15.12% in 2024. The Debt to Equity ratio remained stable at 1.33 in 2025.

Larsen & Toubro - Income Statement (Consolidated):

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
SalesRs 255,734 CroreRs 221,112 CroreRs 183,340 CroreRs 156,521 CroreRs 135,979 Crore
Other IncomeRs 4,124 CroreRs 4,158 CroreRs 2,929 CroreRs 2,267 CroreRs 3,429 Crore
Total IncomeRs 259,859 CroreRs 225,270 CroreRs 186,269 CroreRs 158,788 CroreRs 139,408 Crore
Total ExpenditureRs 232,946 CroreRs 201,207 CroreRs 165,953 CroreRs 141,154 CroreRs 126,815 Crore
EBITRs 26,913 CroreRs 24,062 CroreRs 20,316 CroreRs 17,633 CroreRs 12,593 Crore
InterestRs 3,334 CroreRs 3,545 CroreRs 3,207 CroreRs 3,125 CroreRs 3,913 Crore
TaxRs 5,891 CroreRs 4,947 CroreRs 4,484 CroreRs 4,216 CroreRs 4,010 Crore
Net ProfitRs 17,687 CroreRs 15,569 CroreRs 12,624 CroreRs 10,291 CroreRs 4,668 Crore

The sales of Larsen & Toubro increased from Rs 135,979 Crore in March 2021 to Rs 255,734 Crore in March 2025.

Sun Pharma Financial Overview:

Sun Pharma's consolidated revenue for the quarter-ending June 2025 was Rs 13,851.40 Crore, compared to Rs 12,652.75 Crore in June 2024. The net profit for the same quarter was Rs 2,302.62 Crore, down from Rs 2,871.25 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 9.50, compared to Rs 11.80 in June 2024.

The company's annual consolidated revenue for the year 2025 reached Rs 52,578.44 Crore, a notable increase from Rs 48,496.85 Crore in 2024. The net profit for the year was Rs 10,980.10 Crore, compared to Rs 9,648.44 Crore in the previous year. The EPS for 2025 was Rs 45.60, up from Rs 39.90 in 2024. The Book Value Per Share (BVPS) increased to Rs 301.00 in 2025 from Rs 265.36 in 2024. The Return on Equity (ROE) remained consistent at 15.13% in 2025. The Debt to Equity ratio remained stable at 0.03 in 2025.

Sun Pharma - Income Statement (Consolidated):

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
SalesRs 52,578 CroreRs 48,496 CroreRs 43,885 CroreRs 38,654 CroreRs 33,498 Crore
Other IncomeRs 1,965 CroreRs 1,354 CroreRs 634 CroreRs 921 CroreRs 835 Crore
Total IncomeRs 54,543 CroreRs 49,851 CroreRs 44,520 CroreRs 39,576 CroreRs 34,333 Crore
Total ExpenditureRs 40,559 CroreRs 38,524 CroreRs 34,939 CroreRs 34,967 CroreRs 31,392 Crore
EBITRs 13,983 CroreRs 11,326 CroreRs 9,580 CroreRs 4,608 CroreRs 2,940 Crore
InterestRs 231 CroreRs 238 CroreRs 172 CroreRs 127 CroreRs 141 Crore
TaxRs 2,772 CroreRs 1,439 CroreRs 847 CroreRs 1,075 CroreRs 514 Crore
Net ProfitRs 10,980 CroreRs 9,648 CroreRs 8,560 CroreRs 3,405 CroreRs 2,284 Crore

The sales of Sun Pharma increased from Rs 33,498 Crore in March 2021 to Rs 52,578 Crore in March 2025.

HCL Tech Financial Overview:

HCL Tech's consolidated revenue for the quarter-ending June 2025 stood at Rs 30,349.00 Crore, compared to Rs 28,057.00 Crore in June 2024. The net profit for the same quarter was Rs 3,844.00 Crore, down from Rs 4,259.00 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 14.18, compared to Rs 15.70 in June 2024.

The company's annual consolidated revenue for the year 2025 reached Rs 117,055.00 Crore, a notable increase from Rs 109,913.00 Crore in 2024. The net profit for the year was Rs 17,399.00 Crore, compared to Rs 15,710.00 Crore in the previous year. The EPS for 2025 was Rs 64.16, up from Rs 57.99 in 2024. The Book Value Per Share (BVPS) increased to Rs 256.56 in 2025 from Rs 251.46 in 2024. The Return on Equity (ROE) increased to 24.96% in 2025 from 23.00% in 2024. The Debt to Equity ratio remained stable at 0.03 in 2025.

HCL Tech - Income Statement (Consolidated):

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
SalesRs 117,055 CroreRs 109,913 CroreRs 101,456 CroreRs 85,651 CroreRs 75,379 Crore
Other IncomeRs 2,485 CroreRs 1,495 CroreRs 1,358 CroreRs 1,067 CroreRs 927 Crore
Total IncomeRs 119,540 CroreRs 111,408 CroreRs 102,814 CroreRs 86,718 CroreRs 76,306 Crore
Total ExpenditureRs 95,635 CroreRs 89,888 CroreRs 82,973 CroreRs 69,447 CroreRs 59,942 Crore
EBITRs 23,905 CroreRs 21,520 CroreRs 19,841 CroreRs 17,271 CroreRs 16,364 Crore
InterestRs 644 CroreRs 553 CroreRs 353 CroreRs 319 CroreRs 511 Crore
TaxRs 5,862 CroreRs 5,257 CroreRs 4,643 CroreRs 3,428 CroreRs 4,684 Crore
Net ProfitRs 17,399 CroreRs 15,710 CroreRs 14,845 CroreRs 13,524 CroreRs 11,169 Crore

The sales of HCL Tech increased from Rs 75,379 Crore in March 2021 to Rs 117,055 Crore in March 2025.

Infosys Financial Overview:

Infosys' consolidated revenue for the quarter-ending June 2025 stood at Rs 42,279.00 Crore, compared to Rs 39,315.00 Crore in June 2024. The net profit for the same quarter was Rs 6,924.00 Crore, up from Rs 6,374.00 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 16.70, compared to Rs 15.38 in June 2024.

The company's annual consolidated revenue for the year 2025 reached Rs 162,990.00 Crore, a notable increase from Rs 153,670.00 Crore in 2024. The net profit for the year was Rs 26,750.00 Crore, compared to Rs 26,248.00 Crore in the previous year. The EPS for 2025 was Rs 64.50, up from Rs 63.39 in 2024. The Book Value Per Share (BVPS) increased to Rs 231.11 in 2025 from Rs 212.74 in 2024. The Return on Equity (ROE) decreased to 27.87% in 2025 from 29.77% in 2024. The Debt to Equity ratio remained stable at 0.00 in 2025.

Infosys - Income Statement (Consolidated):

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
SalesRs 162,990 CroreRs 153,670 CroreRs 146,767 CroreRs 121,641 CroreRs 100,472 Crore
Other IncomeRs 3,600 CroreRs 4,711 CroreRs 2,701 CroreRs 2,295 CroreRs 2,201 Crore
Total IncomeRs 166,590 CroreRs 158,381 CroreRs 149,468 CroreRs 123,936 CroreRs 102,673 Crore
Total ExpenditureRs 128,566 CroreRs 121,923 CroreRs 115,862 CroreRs 93,626 CroreRs 75,850 Crore
EBITRs 38,024 CroreRs 36,458 CroreRs 33,606 CroreRs 30,310 CroreRs 26,823 Crore
InterestRs 416 CroreRs 470 CroreRs 284 CroreRs 200 CroreRs 195 Crore
TaxRs 10,858 CroreRs 9,740 CroreRs 9,214 CroreRs 7,964 CroreRs 7,205 Crore
Net ProfitRs 26,750 CroreRs 26,248 CroreRs 24,108 CroreRs 22,146 CroreRs 19,423 Crore

The sales of Infosys increased from Rs 100,472 Crore in March 2021 to Rs 162,990 Crore in March 2025.

ITC Financial Overview:

ITC's consolidated revenue for the quarter-ending June 2025 stood at Rs 21,494.79 Crore, compared to Rs 18,457.33 Crore in June 2024. The net profit for the same quarter was Rs 5,274.65 Crore, up from Rs 5,169.37 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 4.19, compared to Rs 4.08 in June 2024.

The company's annual consolidated revenue for the year 2025 reached Rs 75,323.34 Crore, a notable increase from Rs 70,881.00 Crore in 2024. The net profit for the year was Rs 19,926.05 Crore, compared to Rs 20,723.75 Crore in the previous year. The EPS for 2025 was Rs 27.79, up from Rs 16.42 in 2024. The Book Value Per Share (BVPS) decreased to Rs 55.96 in 2025 from Rs 59.99 in 2024. The Return on Equity (ROE) increased to 49.61% in 2025. The Debt to Equity ratio remained stable at 0.00 in 2025.

ITC - Income Statement (Consolidated):

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
SalesRs 75,323 CroreRs 70,881 CroreRs 70,936 CroreRs 60,668 CroreRs 49,272 Crore
Other IncomeRs 2,529 CroreRs 2,727 CroreRs 1,980 CroreRs 1,836 CroreRs 2,632 Crore
Total IncomeRs 77,853 CroreRs 73,608 CroreRs 72,917 CroreRs 62,504 CroreRs 51,905 Crore
Total ExpenditureRs 50,991 CroreRs 46,450 CroreRs 47,008 CroreRs 41,742 CroreRs 33,915 Crore
EBITRs 26,861 CroreRs 27,158 CroreRs 25,909 CroreRs 20,762 CroreRs 17,989 Crore
InterestRs 45 CroreRs 45 CroreRs 43 CroreRs 39 CroreRs 44 Crore
TaxRs 6,890 CroreRs 6,388 CroreRs 6,438 CroreRs 5,237 CroreRs 4,555 Crore
Net ProfitRs 19,926 CroreRs 20,723 CroreRs 19,427 CroreRs 15,485 CroreRs 13,389 Crore

The sales of ITC increased from Rs 49,272 Crore in March 2021 to Rs 75,323 Crore in March 2025.

Larsen & Toubro has announced a press release on August 13, 2025, regarding L&T Energy GreenTech partnering with Japan's ITOCHU for a Green Ammonia Project. The company also announced the schedule of Analyst / Institutional Investors’ Meet. The company announced a final dividend of Rs 34 on May 8, 2025, with the effective date being June 3, 2025. The company had bonus issues with ratio 1:2 on May 29, 2017 and May 22, 2013.

Sun Pharma announced the schedule of Analyst/Institutional Investor Meeting. The company announced a final dividend of Rs 5.50 per share on May 22, 2025, with the effective date being July 7, 2025. The company had a bonus issue with ratio 1:1 on May 28, 2013. The company had splits with new face value of Rs 1 on September 24, 2010.

HCL Tech has received recognition in six Gartner Voice of the Customer Reports across IT Services Markets. The company announced an interim dividend of Rs 12 per share on July 14, 2025, with the effective date being July 18, 2025. The company had a bonus issue with ratio 1:1 on October 23, 2019.

Infosys joint venture agreement with Telstra Limited. The company announced a final dividend of Rs 22 per share on April 17, 2025, with the effective date being May 30, 2025. The company had a bonus issue with ratio 1:1 on July 13, 2018.

ITC has announced scheme of amalgamation of Sresta Natural Bioproducts Private Limited and Wimco Limited with ITC Limited. The company announced a final dividend of Rs 7.85 per share on May 22, 2025, with the effective date being May 28, 2025. The company had a bonus issue with ratio 1:2 on May 20, 2016. The company had splits with new face value of Rs 1 on June 17, 2005.

Moneycontrol analysis indicates a very bullish sentiment for the stock as of August 18, 2025.

Alpha Desk
first published: Aug 18, 2025 10:41 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347